Tìm kiếm
Spero Therapeutics Inc
SPROThêm vào danh sách theo dõi
1.265USD
+0.005+0.40%
Giờ giao dịch 09/24, 10:34（ET）
73.24MVốn hóa
4.56P/E TTM
Giới thiệu về Spero Therapeutics Inc Công ty
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying and developing novel treatments for rare diseases and diseases caused by multi-drug resistant (MDR) bacterial infections with unmet need. Its product candidate SPR720 is an investigational, chemically stable phosphate ester prodrug that is converted in vivo to SPR719 for the treatment of nontuberculous mycobacterial (NTM) pulmonary disease. Its clinical stage product candidate, tebipenem HBr is an investigational oral carbapenem antibiotic being developed for the treatment of complicated urinary tract infections (cUTIs) including acute pyelonephritis (AP) to help patients potentially reduce duration of in-patient therapy.
Spero Therapeutics Inc Hồ sơ
Mã chứng khoánSPRO
Tên công tySpero Therapeutics Inc
Ngày IPONov 02, 2017
Giám đốc điều hànhRajavelu (Esther)
Số lượng nhân viên32
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhNov 02
Địa chỉ675 Massachusetts Ave Ste 14
Thành phốCAMBRIDGE
Sàn giao dịch chứng khoánNASDAQ OMX - NASDAQ BASIC
Quốc giaUnited States of America
Mã bưu điện02139-3309
Điện thoại18572421600
Trang webhttps://sperotherapeutics.com/
Mã chứng khoánSPRO
Ngày IPONov 02, 2017
Giám đốc điều hànhRajavelu (Esther)
Lãnh đạo công ty của Spero Therapeutics Inc
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Dr. Ankit Mahadevia, M.D.
Dr. Ankit Mahadevia, M.D.
Non-Executive Director
Non-Executive Director
364.22K
-1.80%
Mr. Timothy (Tim) Keutzer
Mr. Timothy (Tim) Keutzer
Chief Operating Officer
Chief Operating Officer
335.13K
+55.82%
Mr. Timothy (Tim) Keutzer
Mr. Timothy (Tim) Keutzer
Chief Operating Officer
Chief Operating Officer
335.13K
+55.82%
Mr. Timothy (Tim) Keutzer
Mr. Timothy (Tim) Keutzer
Chief Operating Officer
Chief Operating Officer
335.13K
+55.82%
Ms. Esther Rajavelu
Ms. Esther Rajavelu
President, Chief Executive Officer, Chief Financial Officer, Treasurer and Chief Business Officer
President, Chief Executive Officer, Chief Financial Officer, Treasurer and Chief Business Officer
229.84K
-10.98%
Ms. Esther Rajavelu
Ms. Esther Rajavelu
President, Chief Executive Officer, Chief Financial Officer, Treasurer and Chief Business Officer
President, Chief Executive Officer, Chief Financial Officer, Treasurer and Chief Business Officer
229.84K
-10.98%
Ms. Esther Rajavelu
Ms. Esther Rajavelu
President, Chief Executive Officer, Chief Financial Officer, Treasurer and Chief Business Officer
President, Chief Executive Officer, Chief Financial Officer, Treasurer and Chief Business Officer
229.84K
-10.98%
Dr. Milind S. Deshpande, Ph.D.
Dr. Milind S. Deshpande, Ph.D.
Independent Director
Independent Director
81.45K
+12.28%
Dr. Milind S. Deshpande, Ph.D.
Dr. Milind S. Deshpande, Ph.D.
Independent Director
Independent Director
81.45K
+12.28%
Dr. Milind S. Deshpande, Ph.D.
Dr. Milind S. Deshpande, Ph.D.
Independent Director
Independent Director
81.45K
+12.28%
Xem thêm
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Dr. Ankit Mahadevia, M.D.
Dr. Ankit Mahadevia, M.D.
Non-Executive Director
Non-Executive Director
364.22K
-1.80%
Mr. Timothy (Tim) Keutzer
Mr. Timothy (Tim) Keutzer
Chief Operating Officer
Chief Operating Officer
335.13K
+55.82%
Mr. Timothy (Tim) Keutzer
Mr. Timothy (Tim) Keutzer
Chief Operating Officer
Chief Operating Officer
335.13K
+55.82%
Mr. Timothy (Tim) Keutzer
Mr. Timothy (Tim) Keutzer
Chief Operating Officer
Chief Operating Officer
335.13K
+55.82%
Ms. Esther Rajavelu
Ms. Esther Rajavelu
President, Chief Executive Officer, Chief Financial Officer, Treasurer and Chief Business Officer
President, Chief Executive Officer, Chief Financial Officer, Treasurer and Chief Business Officer
229.84K
-10.98%
Ms. Esther Rajavelu
Ms. Esther Rajavelu
President, Chief Executive Officer, Chief Financial Officer, Treasurer and Chief Business Officer
President, Chief Executive Officer, Chief Financial Officer, Treasurer and Chief Business Officer
229.84K
-10.98%
Câu hỏi thường gặp
Ai là năm cổ đông lớn nhất của Spero Therapeutics Inc?
Năm cổ đông hàng đầu của Spero Therapeutics Inc là: Dr. Ankit Mahadevia, M.D.
Có bao nhiêu tổ chức nắm giữ cổ phiếu của Spero Therapeutics Inc (SPRO)?
Tính đến ngày 2026Q1, có 117 tổ chức nắm giữ cổ phiếu của Spero Therapeutics Inc, với tổng giá trị thị trường khoảng 11.81M, chiếm 20.40% tổng số cổ phiếu. So với ngày 2025Q4, tỷ lệ cổ phần của các tổ chức đã tăng thêm -1291189.00.